A peptide certificate of analysis, often shortened to COA, is useful when it answers a defined question about an identified sample. To read it well, start with the sample and the method, then interpret the result. Beginning with the largest percentage on the page can leave important details unchecked.
This guide explains a practical reading sequence for Australian research buyers. It also separates document verification from the question of whether the tested sample represents the product being offered.
1. Identify the sample before interpreting the numbers
Find the product or sample name, nominal presentation, report number, laboratory and analysis date. Look for a batch or lot identifier and compare it with the information attached to the order.
If the identifiers do not match, record the discrepancy and ask for clarification. A missing link does not by itself establish that a report is false, but it leaves a question unresolved. Do not silently substitute a report for another strength or a different lot.
Keep a copy of the complete report. A cropped image showing only the result may omit information needed to interpret it. Your record should preserve enough context for another person to follow the same verification steps.
2. Understand the difference between identity, purity and content
Analytical specifications distinguish questions about identity, content and impurities. ICH Q6A discusses these as separate elements of drug-substance and product specifications. Those distinctions help explain reports; citing the guideline does not establish that a catalogue material meets pharmaceutical manufacturing requirements. [1]
| Report item | Question it helps address | Detail to check |
|---|---|---|
| Identity | What material was detected? | Method and identification conclusion |
| Chromatographic purity | What proportion of the measured chromatographic response is assigned to the target? | Method, detector and reporting basis |
| Content or amount | How much material was measured in the submitted sample? | Units, method and whether the result is per vial |
| Specified contaminants | What was found for the substances or organisms tested? | Test scope and detection or reporting limits |
For HPLC with UV detection, Bachem explains purity in relation to the material detected under the analytical conditions. It separately explains net peptide content and the contribution of counter-ions and water to gross sample weight. A chromatographic percentage therefore should not be read as a universal statement about everything in a vial. [2]
3. Read each result with its units and limits
Write the result exactly as reported, including the unit and any “less than” sign. Ask for an explanation if a report gives a conclusion without enough context to understand it.
An amount per vial and a purity percentage answer different questions. Neither should be substituted for the other. For a blend, establish which components were identified or quantified; a total label amount does not supply an individual analytical result for every component.
Comparisons also need comparable methods. A small numerical difference between two reports should not automatically become a quality ranking. Work on peptide reference materials by Josephs and colleagues examined several approaches to assigning purity mass fraction, illustrating the importance of measurement method and traceability. [3]
4. Check the microbiological test by name
Read the test method rather than relying solely on the heading above a report image. USP lists microbial enumeration under Chapter 61 and sterility testing under Chapter 71. A microbial count result and a sterility test should be described using their actual methods. [4] [5]
For sterility testing, record the findings and test conditions exactly as printed. Keep the sample identifier, report date and batch with the result. [4]
Bacterial endotoxin testing is another defined analytical question. The FDA's current guidance addresses specific methods and acceptance criteria for regulated products; it does not create one universal “safe” endotoxin number for every material or purpose. [6]
5. Verify the report and the batch connection
Use the “Verify on Kovera Labs” link for the individual certificate, then compare the laboratory record with the displayed report: sample or report identifier, product, strength, batch, dates, tests and results. Each certificate links to its Kovera Labs verification record, so the report ID and batch can be matched to the supplied stock. Document authentication and matching the report to the material offered are separate checks. See our report-reading guide. [7]
Then confirm the connection to the selected product. The following are useful questions to send together:
- Which report applies to the exact product presentation I have selected?
- How is the supplied lot identified on the order or packaging?
- Which identity, amount and other test results are available for that sample?
- Are any relevant tests absent or awaiting clarification?
This is a document-reading checklist. It is not a replacement for the laboratory's interpretation or your organisation's acceptance procedure.
Reading reports alongside the catalogue
The Eternal Peptides Wholesale testing page provides context for the published laboratory information. Individual pages, including MOTS-C 10mg, display report sections alongside the product description. Read the underlying documents for their actual scope. You can also browse published COAs by product in the COA library. [8] [9]
A complete review ends with a clear record of what has been established and what still requires an answer. If a report or batch link is unclear, use the contact page with the product code and report identifier so the question can be addressed precisely.
Peptide purity testing and peptide batch testing: what to request
Peptide purity testing should name the method and explain the reported result. Peptide batch testing should also make the sample-to-lot connection clear. Before comparing two certificates, check that they answer the same analytical question: a purity percentage and a measured mass are not interchangeable results. [1]
If you request a peptide supplier certificate of analysis, specify the product code and offered lot, then ask for the full document. Record any test that your project needs but that the document does not cover. A missing result is an open question, not a result you can infer from another measurement.
Checking Kovera Labs reports in Australia
For Australian buyers reviewing Kovera Labs peptide reports, verify the document through its laboratory link, compare the sample description with the offer, and confirm the lot connection with the seller. The verification page supports the document check; it does not establish the delivery’s traceability on your behalf. [7]
When comparing peptide testing in Australia, separately identify the seller's location and the laboratory that performed the work. Local purchasing does not establish where analysis occurred or which activities an accreditation covers. [10]
Related from Eternal Peptides Wholesale
Eternal Peptides Wholesale publishes batch-specific Kovera Labs reports in its certificate of analysis library, so the documentation for a listed batch can be read alongside the evidence discussed in this article.
- Kovera Labs. Published Kovera Labs reports and testing scope. Reports reviewed 1 November 2026; open the individual certificate and its laboratory verification link.
- Evidence review: Peptides wholesale: supplier qualification and quality standards
Related reading: Certificate of Analysis: 2026 Research Peptides Guide
References and bibliography
- International Council for Harmonisation; US Food and Drug Administration. (2000). Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. Accessed 27 September 2026.
- Bachem. (2021). FAQ – frequently asked questions: analysis of peptides. Accessed 27 September 2026.
- Josephs RD, Stoppacher N, Daireaux A, Choteau T, Lippa K, Phinney K, Westwood S, Wielgosz R. (2018). State-of-the-art and trends for the SI traceable value assignment of the purity of peptides using the model compound angiotensin I. TrAC Trends in Analytical Chemistry. 101. DOI: 10.1016/j.trac.2017.09.026. Accessed 27 September 2026.
- United States Pharmacopeia. (2024). General Chapter 61: Microbiological Examination of Nonsterile Products—Microbial Enumeration Tests. DOI: 10.31003/USPNF_M98800_01_01. Accessed 27 September 2026.
- United States Pharmacopeia. (2017). General Chapter 71: Sterility Tests. DOI: 10.31003/USPNF_M98810_01_01. Accessed 27 September 2026.
- US Food and Drug Administration. (2026). Pyrogen and Endotoxins Testing: Questions and Answers. Accessed 27 September 2026.
- Kovera Labs. Certificate verification links and sample/batch checks. Reports reviewed 1 November 2026; open the individual certificate and its laboratory verification link.
- Eternal Peptides Wholesale. Our Peptide Testing Standards. Accessed 27 September 2026.
- Eternal Peptides Wholesale. MOTS-C (10mg), product MC10. Accessed 27 September 2026.
- National Association of Testing Authorities, Australia. ISO/IEC 17025 Testing & Calibration. Accessed 27 September 2026.
Testing references updated 1 November 2026 for the published Kovera Labs report set. Original research and catalogue snapshot dates remain as stated.